/
31 st  Annual Report on 31 st  Annual Report on

31 st Annual Report on - PowerPoint Presentation

ruby
ruby . @ruby
Follow
342 views
Uploaded On 2022-02-12

31 st Annual Report on - PPT Presentation

Liver and Intestinal Transplantation Activity in Australia and New Zealand Data to 31 December 2019 15 Liver Transplantation and Cancer Cancer in liver transplant recipients Type of liver cancers as a primary diagnosis ID: 908260

diagnosis cancer skin liver cancer diagnosis liver skin novo cancers type patient pretransplant survival transplant patients time transplantation types

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "31 st Annual Report on" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

31st Annual Report on Liver and Intestinal Transplantation Activityin Australia and New ZealandData to 31 December 2019

Slide2

15 Liver Transplantation and Cancer

Slide3

Cancer in liver transplant recipients

Slide4

Type of liver cancers as a primary diagnosis

Slide5

Patient survival curve for patients with a primary diagnosis of liver cancer

Slide6

Patient survival curve for patients with a primary diagnosis of liver cancer by type of cancer

Slide7

Incidence of patients with liver cancer as a primary diagnosis by era

Slide8

Type of liver cancers as a secondary / incidental diagnosis

Slide9

Patient survival curve for patients with a secondary / incidental diagnosis of liver cancer

Slide10

Patient survival curve for patients with secondary / incidental diagnosis of liver cancer by type of cancer

Slide11

Types of liver cancer (primary or secondary / incidental diagnosis) at transplantation

Slide12

Patient survival – pretransplant benign disease versus pretransplant liver malignancy

Slide13

Hepatocellular carcinoma versus other liver cancers at transplantation by era

Slide14

Hepatocellular carcinoma status at transplant by era

Slide15

Patient survival of hepatocellular carcinoma by era

Slide16

De novo non-skin cancer types

*28 patients developed more than 1 non-skin cancer post-transplant

Slide17

De novo non-skin cancer types

Slide18

Time to diagnosis of de novo non-skin cancer

Slide19

Time to diagnosis of any non-skin cancer by age category

Slide20

Pretransplant diagnosis and de novo non-skin cancer types

Slide21

Hepatitis C virus and alcohol diagnosis and types of de novo skin cancer

Slide22

Time to diagnosis of de novo lymphoma by age category

Slide23

Pretransplant diagnosis and de novo genitourinary cancers

Slide24

Incidence of de novo genitourinary tract cancers by type

Slide25

Pretransplant diagnosis and de novo alimentary cancers

Slide26

Incidence of de novo alimentary tract cancers by type

Slide27

Pretransplant diagnosis and de novo respiratory cancers

* 1 patient had 2

respiratory

cancers

Slide28

Incidence of de novo respiratory tract cancers by type

Slide29

Time to first skin cancer development post-transplant by type of skin cancer

Slide30

Time to first melanoma development post-transplant

Slide31

Time to any skin cancer development post-transplant

Slide32

Cumulative risk of diagnosis of skin or non-skin cancer following liver transplantation